loader2
Partner With Us NRI

Apollo Hospitals Enterprise Ltd share Price Today

Company details

5,753.25
5,881.00
4,410.25
6,874.45
6M Return 10.28%
1Y Return 27.20%
Mkt Cap.(Cr) 84,005.67
Volume 3,72,227
Div Yield 0.26%
OI
-
OI Chg %
-
Volume 3,72,227

Invest in Market with Confidence: High performance strike rate of over 72%

Trade, sell, withdraw – all in minutes!
icon 27 Years

of legacy

icon 4.4 Star

App Rating

icon 1 Crore +

Customers

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number

Healthcare Facilities company Apollo Hospitals Enterprise announced Q3FY24 & 9MFY24 results:

Consolidated Q3FY24:

  • Revenues at Rs 48,506 million vs Rs 42,636 million in Q3FY23; growth of 14% YoY
  • EBITDA at Rs 6,137 million vs Rs 5,053 million in Q3FY23. This is after Apollo 247 cost of Rs 1,557 million in the quarter (including Rs 141 million non-cash ESOP charge) vs Rs 2,024 million in Q3 FY23.
  • Reported PAT at Rs 2,453 million vs Rs 1,535 million in Q3FY23
  • Diluted EPS of Rs 17.06 per share in Q3FY24 (not annualized)

Consolidated 9MFY24:

  • Revenue at Rs 141,153 million vs Rs123,103 million in 9MFY24; growth of 15% YoY
  • EBITDA at Rs 17,502 million vs Rs 15,615 million in 9MFY23. This is after Apollo 247 cost of Rs 5,569 million for 9M(including Rs 785 million non-cash ESOP charge) vs Rs 5,181 million in 9MFY23.
  • PAT stood at Rs 6,448 million vs Rs 5,315 million in 9MFY23
  • Reported PAT stood at Rs 6,448 million vs Rs 6,746 million in 9MFY23
  • Diluted EPS of Rs 44.84 per share in 9MFY24

Health Care service Q3FY24 Performance:

  • Revenue at Rs 24,635 million vs Rs 21,944 million in Q3 FY23; growth of 12% YoY
  • EBITDA grew by 8% at Rs 5,860 million vs Rs 5,428 million in Q3FY23; Margins at 23.8% in Q3FY24
  • PAT stood at Rs 2,872 million vs Rs 2,609 million in Q3FY23, 10% growth

Health Care service 9MFY24 Performance:

  • Revenue at Rs 73,044 million vs Rs 64,823 million in 9MFY23; growth of 13% YoY
  • EBITDA grew by 10% at Rs 17,627 million vs Rs 15,984 million in 9MFY23; Margins at 24.1% in 9MFY24
  • PAT stood at Rs 8,648 million vs Rs 9,043 million in 9MFY23

Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, "In the pursuit of a healthier nation, Apollo remains steadfast in its belief in the importance of preventive healthcare. Our mission is to empower individuals to safeguard their well-being, preventing the onset of NonCommunicable Diseases (NCDs). In a country where 5.8 million lives are claimed annually by NCDs, and 1 in 4 Indians faces the risk of such an outcome before the age of 70, Apollo ProHealth emerges as a beacon of comprehensive personalized prevention. Combining medical expertise with Artificial Intelligence, this program, curated by skilled physicians, evaluates overall health, predicts risks, and guides individuals on a personalized path to wellness. It equips you with the tools and knowledge to make proactive choices for your well-being.

Our vision is resolute – to integrate preventive healthcare into the lives of every Indian. More than a business objective, it's a commitment to our nation's health. Together, let's strive to nurture countless healthy and happy families, shielding them from the growing threat of noncommunicable diseases.”

Result PDF

View Other Company Results

Apollo Hospitals Enterprise Ltd shares SWOT Analysis

Strengths (6)

  • Growth in Net Profit with increasing Profit Margin (QoQ)
  • Company with Low Debt
  • Increasing Revenue every Quarter for the past 4 Quarters

Weakness (1)

  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (0)

Data not found

Threats (4)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 5,897.9
R2 5,953.3
R3 6,025.6
Pivot

5,825.57

S1 5,770.1
S2 5,697.8
S3 5,642.4
EMA SMA
6,065.8
6,150.2
6,036.8
5,717.0
6,123.7
6,194.4
6,131.6
5,620.5
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
AIA VCC - AIA ASIAN EQUITY FUND Block Purchase 2023-11-16 5311.25 22091 BSE
AIA INTERNATIONAL LIMITED Block Sell 2023-11-16 5311.25 22091 BSE
AIA VCC - AIA ASIAN EQUITY FUND Block Purchase 2023-10-19 5009.95 42216 BSE
Name Category Shares
Ms. Suneeta Reddy PROMOTER 3.36%
Ms. Sangita Reddy PROMOTER 1.69%
Ms. Shobana Kamineni PROMOTER 1.56%
Mr. K Vishweshwar Reddy PROMOTER 1.1%
Ms. Preetha Reddy PROMOTER 0.73%
M/s. PCR Investments Ltd PROMOTER 18.93%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Apollo Hospitals Enterprise Ltd Stocks COMPARISON

Financials( in Cr) Apollo Hospitals Enterprise Ltd Max Healthcare Institute Ltd Global Health Ltd Fortis Healthcare Ltd Narayana Hrudayalaya Ltd
Price 5,842.45 811.40 1,412.05 441.60 1,262.20
% Change 0.62 1.92 1.03 -2.32 1.58
Mcap Cr 84,005.67 78,860.94 37,914.53 33,338.95 25,794.45
Revenue TTM Cr 16,612.50 4,831.37 2,694.25 6,537.06 4,524.77
Net Profit TTM Cr 887.50 1,103.51 326.08 632.98 606.57
PE TTM 106.44 74.45 84.05 62.22 33.41
1 Year Return 27.20 68.59 174.77 63.46 66.92
ROCE 14.16 13.85 16.49 7.51 29.27
ROE 15.04 16.12 16.13 6.79 33.51
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 6,197.40 Cr FV: 5.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 40,292.52 -39,101.37
LAST 3M 97,195.39 -16,897.62
LAST 6M 1,59,485.99 61,690.63
LAST 12M 2,49,857.63 1,46,087.29
Apollo Hospitals Enterprise Limited - Updates

May 10, 2024 l NSE Announcement

Apollo Hospitals Enterprise Limited - Change in Director

May 07, 2024 l NSE Announcement

Apollo Hospitals Enterprise Limited - Analysts/Institutional Investor Meet/Con. Call Updates

May 06, 2024 l NSE Announcement

Date Action Type Ratio
Feb 20, 2024 Dividend 120
Aug 18, 2023 Dividend 180
Feb 24, 2023 Dividend 120

Apollo Hospitals Enterprise Ltd Information

Stock PE (TTM)
106.44
Promoter Holding
29.33%
Book Value
452.12
ROCE
14.16%
ROE
15.04%
Registered Address

No 19 Bishop Garden, Raja Annamalaipuram, Chennai, Tamil Nadu, 600028

Tel : 91-44-28290956/28293896
Email : investor.relations:apollohospitals.com
Website : http://www.apollohospitals.com
Registrar

Integrated Registry Mgt Servic

AGM Date (Month) : Aug
Face Value Equity Shares : 5
Market Lot Equity Shares : 1
BSE Code : 508869
NSE Code : APOLLOHOSP
Book Closure Date (Month) :
BSE Group : A
ISIN : INE437A01024

FAQ’s on Apollo Hospitals Enterprise Ltd Shares

You can buy Apollo Hospitals Enterprise Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Apollo Hospitals Enterprise Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 10, 2024 03:59 PM the closing price of Apollo Hospitals Enterprise Ltd was Rs.5,842.45.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 10, 2024 03:59 PM, the market cap of Apollo Hospitals Enterprise Ltd stood at Rs. 84,005.67.

The latest PE ratio of Apollo Hospitals Enterprise Ltd as of May 10, 2024 03:59 PM is 106.44

The latest PB ratio of Apollo Hospitals Enterprise Ltd as of May 10, 2024 03:59 PM is 0.08

The 52-week high of Apollo Hospitals Enterprise Ltd share price is Rs. 6,874.45 while the 52-week low is Rs. 4,410.25

According to analyst recommendations, Apollo Hospitals Enterprise Ltd Share has a "" rating for the long term.

Download App

Download Our App

Play Store App Store
market app

Open a Trading Account

Achieve your Investment goals today!

+91
Please enter valid Mobile Number